A. Rose Brannon

7.9k total citations · 1 hit paper
52 papers, 2.7k citations indexed

About

A. Rose Brannon is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, A. Rose Brannon has authored 52 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Cancer Research, 23 papers in Molecular Biology and 23 papers in Pulmonary and Respiratory Medicine. Recurrent topics in A. Rose Brannon's work include Cancer Genomics and Diagnostics (29 papers), Renal cell carcinoma treatment (15 papers) and Renal and related cancers (8 papers). A. Rose Brannon is often cited by papers focused on Cancer Genomics and Diagnostics (29 papers), Renal cell carcinoma treatment (15 papers) and Renal and related cancers (8 papers). A. Rose Brannon collaborates with scholars based in United States, Spain and Netherlands. A. Rose Brannon's co-authors include W. Kimryn Rathmell, Michael F. Berger, A. Ari Hakimi, James J. Hsieh, Paul Russo, Ying‐Bei Chen, Victor E. Reuter, Sasinya N. Scott, Satish K. Tickoo and Matthew E. Nielsen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

A. Rose Brannon

49 papers receiving 2.6k citations

Hit Papers

An Integrated Metabolic Atlas of Clear Cell Renal Cell Ca... 2016 2026 2019 2022 2016 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma
    2016 531 citations A. Ari Hakimi, Ed Reznik et al. Cancer Cell profile →

Peers

A. Rose Brannon
Bungo Furusato United States
Daniel Nava Rodrigues United Kingdom
Paul Geeleher United States
Ole J. Halvorsen Norway
Karina D. Sørensen Denmark
Rebeca Sanz‐Pamplona Spain
Ergin Kilic Germany
Stephen Q. Wong Australia
Sylvie Gazzéri France
Ronglai Shen United States
Bungo Furusato United States
A. Rose Brannon
Citations per year, relative to A. Rose Brannon A. Rose Brannon (= 1×) peers Bungo Furusato

Countries citing papers authored by A. Rose Brannon

Since Specialization
Citations

This map shows the geographic impact of A. Rose Brannon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Rose Brannon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Rose Brannon more than expected).

Fields of papers citing papers by A. Rose Brannon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Rose Brannon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Rose Brannon. The network helps show where A. Rose Brannon may publish in the future.

Co-authorship network of co-authors of A. Rose Brannon

This figure shows the co-authorship network connecting the top 25 collaborators of A. Rose Brannon. A scholar is included among the top collaborators of A. Rose Brannon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Rose Brannon. A. Rose Brannon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vanderbilt, Chad, Soo‐Ryum Yang, Subhiksha Nandakumar, et al.. (2025). Maximizing the clinical utility and performance of cytology samples for comprehensive genetic profiling. Nature Communications. 16(1). 116–116. 2 indexed citations
2.
Benhamida, Jamal, Laetitia Borsu, Liliana Villafania, et al.. (2025). Methylation Analysis Reveals Epigenetic Congruence Between Bone Sarcomas With H3-3A Mutations and Malignant Giant Cell Tumors of Bone. Modern Pathology. 38(7). 100763–100763. 1 indexed citations
3.
Hechtman, Jaclyn F., Satshil Rana, Ryan Ptashkin, et al.. (2025). A deep multiple instance learning framework improves microsatellite instability detection from tumor next generation sequencing. Nature Communications. 16(1). 136–136.
4.
Suehnholz, Sarah P., Ritika Kundra, Hongxin Zhang, et al.. (2024). Tracking the FDA precision oncology drug approval landscape in OncoKB.. Journal of Clinical Oncology. 42(16_suppl). e13507–e13507. 1 indexed citations
5.
Wenger, Yvan, Jacklyn Casanova, Anita S. Bowman, et al.. (2024). MSK-ACCESS powered with SOPHiA DDM: Performance analysis of a decentralized MSK-ACCESS solution.. Journal of Clinical Oncology. 42(16_suppl). e15063–e15063.
6.
Stonestrom, Aaron J., Kamal Menghrajani, Sean M. Devlin, et al.. (2023). High-risk and silent clonal hematopoietic genotypes in patients with nonhematologic cancer. Blood Advances. 8(4). 846–856. 5 indexed citations
7.
Hickman, Richard A., Erika Gedvilaite, Ryan Ptashkin, et al.. (2023). CDKN2A/B mutations and allele-specific alterations stratify survival outcomes in IDH-mutant astrocytomas. Acta Neuropathologica. 146(6). 845–847. 12 indexed citations
8.
Abramson, David H., Diana Mandelker, Jasmine H. Francis, et al.. (2021). Retrospective Evaluation of Somatic Alterations in Cell-Free DNA from Blood in Retinoblastoma. SHILAP Revista de lepidopterología. 1(1). 100015–100015. 17 indexed citations
9.
Francis, Jasmine H., Y. Pierre Gobin, A. Rose Brannon, et al.. (2021). RB1 Circulating Tumor DNA in the Blood of Patients with Unilateral Retinoblastoma. SHILAP Revista de lepidopterología. 1(3). 100042–100042. 10 indexed citations
10.
Piperno‐Neumann, Sophie, James Larkin, Richard D. Carvajal, et al.. (2020). Genomic Profiling of Metastatic Uveal Melanoma and Clinical Results of a Phase I Study of the Protein Kinase C Inhibitor AEB071. Molecular Cancer Therapeutics. 19(4). 1031–1039. 41 indexed citations
11.
Hakimi, A. Ari, Ed Reznik, Chung‐Han Lee, et al.. (2016). An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma. Cancer Cell. 29(1). 104–116. 531 indexed citations breakdown →
12.
Brannon, A. Rose, Melissa Frizziero, David Chen, et al.. (2015). Molecular analysis of a male breast cancer patient with prolonged stable disease under mTOR/PI3K inhibitors BEZ235/everolimus. Molecular Case Studies. 2(2). a000620–a000620. 6 indexed citations
13.
Voss, Martin H., A. Ari Hakimi, Can G. Pham, et al.. (2014). Tumor Genetic Analyses of Patients with Metastatic Renal Cell Carcinoma and Extended Benefit from mTOR Inhibitor Therapy. Clinical Cancer Research. 20(7). 1955–1964. 156 indexed citations
14.
Debebe, Zufan, Tricia M. Wright, Samira A. Brooks, et al.. (2014). Expression of Ror2 Mediates Invasive Phenotypes in Renal Cell Carcinoma. PLoS ONE. 9(12). e116101–e116101. 23 indexed citations
15.
Simon, Jeremy M., Kathryn E. Hacker, Darshan Singh, et al.. (2013). Variation in chromatin accessibility in human kidney cancer links H3K36 methyltransferase loss with widespread RNA processing defects. Genome Research. 24(2). 241–250. 137 indexed citations
16.
Won, Helen, Sasinya N. Scott, A. Rose Brannon, Ronak Shah, & Michael F. Berger. (2013). Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing. Journal of Visualized Experiments. e50710–e50710. 44 indexed citations
17.
Liu, Huiqing, A. Rose Brannon, Anupama Reddy, et al.. (2010). Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell Renal Cell Carcinoma. BMC Systems Biology. 4(1). 51–51. 205 indexed citations
18.
Brannon, A. Rose & W. Kimryn Rathmell. (2010). Renal Cell Carcinoma: Where Will the State-of-the-Art Lead Us?. Current Oncology Reports. 12(3). 193–201. 12 indexed citations
19.
Reddy, Anupama, A. Rose Brannon, Michael Seiler, et al.. (2009). A Predictor for Survival in Intermediate Grade Clear Cell Renal Cell Carcinoma.. 441–447. 1 indexed citations
20.
Wright, Tricia M., A. Rose Brannon, John D. Gordan, et al.. (2009). Ror2, a developmentally regulated kinase, promotes tumor growth potential in renal cell carcinoma. Oncogene. 28(27). 2513–2523. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bungo Furusato Breakdown of academic impact, for papers by Daniel Nava Rodrigues Breakdown of academic impact, for papers by Paul Geeleher Breakdown of academic impact, for papers by Ole J. Halvorsen Breakdown of academic impact, for papers by Karina D. Sørensen Breakdown of academic impact, for papers by Rebeca Sanz‐Pamplona Breakdown of academic impact, for papers by Ergin Kilic Breakdown of academic impact, for papers by Stephen Q. Wong Breakdown of academic impact, for papers by Sylvie Gazzéri Breakdown of academic impact, for papers by Ronglai Shen
Rankless by CCL
2026